ArticleYonsei medical journal2025

Elevated Soluble Suppressor of Tumorigenicity 2 Levels in Gout Patients and Its Association with Cardiovascular Disease Risk Indicators.

Jiyoung Agatha Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.